Biomedical Centre Faculty of Medicine in Pilsen Charles University Alej Svobody 76 323 00 Pilsen Czech Republic

Department of Molecular Biology of Cancer Institute of Experimental Medicine of the Czech Academy of Sciences Videnska 1083 142 00 Prague Czech Republic

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Albertov 4 128 00 Prague Czech Republic

Zobrazit více v PubMed

Vodickova L, Horak J, Vodicka P.. Genetic susceptibility in understanding of pancreatic ductal adenocarcinoma risk: a decade-long effort of the PANDORA consortium. Cancer Epidemiol Biomarkers Prev 2022;31:942–8. https://doi.org/10.1158/1055-9965.EPI-21-1340 PubMed DOI PMC

Campa D, Gentiluomo M, Stein A, et al.The PANcreatic Disease ReseArch (PANDoRA) consortium: ten years experience of association studies to understand the genetic architecture of pancreatic cancer. Crit Rev Oncol Hematol 2023;186:104020. https://doi.org/10.1016/j.critrevonc.2023.104020 PubMed DOI

Pardini B, Ferrero G, Tarallo S, et al.A fecal miRNA signature by small RNA sequencing accurately distinguishes colorectal cancers: results from a multicentric study. Gastroenterology 2023;165:582–99. https://doi.org/10.1053/j.gastro.2023.05.037 PubMed DOI

Huyghe JR, Bien SA, Harrison TA, et al.Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet 2019;1:76–87. https://doi.org/10.1038/s41588-018-0286-6 PubMed DOI PMC

Fernandez-Rozadilla C, Timofeeva M, Chen Z, et al.Multi-omic analysis of 100,204 Europeans and Asians identifies 103 new colorectal cancer risk associations and provides insights into disease etiology. Nat Genet 2023;1:89–99. https://doi.org/10.1038/s41588-022-01222-9 PubMed DOI PMC

Huyghe JR, Harrison TA, Bien SA, et al.Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut 2021;70:1325–34. PubMed PMC

Archambault AA, Su Y, Jeon J, et al.Cumulative burden of colorectal cancer-associated genetic variants is more strongly associated with early-onset vs late-onset cancer. Gastroenterology 2020;158:1274. PubMed PMC

Murphy N, Moreno V, Hughes DJ, et al.Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Mol Aspects Med 2019;69:2–9. PubMed

Vodicka P, Kroupa M, Vodickova L, et al.Current understanding of genomic and chromosomal instabilities in solid malignancies. Front Oncol 2023;13:1245087. https://doi.org/10.3389/fonc.2023.1245087 PubMed DOI PMC

Andarawi S, Vodickova L, Uttarilli A, et al.The DNA damage and repair in malignant, neurodegenerative diseases, human immunological disorders and aging. Mutagenesis 2024, In this Issue.

Eid MT, Taslerová J, Gryc M R, et al.Incidental germline findings during comprehensive genomic profiling of pancreatic and colorectal cancer: single-centre, molecular tumour board experience. Mutagenesis 2024, In this Issue. PubMed PMC

Hemminki K, Niazi Y, Vodickova L, et al.Genetic and environmental associations of nonspecific chromosomal aberrations. Mutagenesis 2024, In this Issue. PubMed PMC

Campa D, Felici A, Corradi C, et al.Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review. Mutagenesis 2024, In this Issue. PubMed

Tomasova K, Kroupa M, Zinkova A, et al.Monitoring of telomere dynamics in peripheral blood leukocytes in relation to colorectal cancer patients’ outcomes. Front Oncol 2022;12:962929. https://doi.org/10.3389/fonc.2022.962929.eCollection2022 PubMed DOI PMC

Mandle H, Jenab M, Gunter M, et al.Inflammation and gut barrier function-related genes and colorectal cancer risk in Western European populations. Mutagenesis 2024, In this Issue. PubMed PMC

Hackert T, Giaccherini M, Rende M, et al.A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma. Mutagenesis 2024, In this Issue. PubMed

Naccarati A, Dragomir MP, Tarallo S, Gagliardi A. et al. Investigating faecal miRNA profiles in colorectal cancer with mucinous morphology. Mutagenesis 2024, In this Issue. PubMed

Vokacova K, Landecka A, Selvi S, et al.Plasma miR-122-5p. and miR-142-5p. and their role in chemoresistance of colon cancer patients. Mutagenesis 2024, In this Issue. PubMed

Horak J, Dolnikova A, Cumaogullari O, et al.MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients. Front Oncol 2022;12:959407. https://doi.org/10.3389/fonc.2022.95940 PubMed DOI PMC

Horak J, Vallusova D, Andrea Cumova A, et al.Inhibition of homologous recombination repair by Mirin in ovarian cancer ameliorates carboplatin therapy response in vitro. Mutagenesis 2024, In this Issue. PubMed